Management of Non-Healing Ruptured Bulla

Introduction to Management

• The British Journal of Dermatology recommends immediate wound care with gentle cleansing, leaving the blister roof intact as a biological dressing, applying bland emollient, and ruling out infection for a single ruptured bulla on the calf without systemic symptoms that is not healing, with urgent evaluation for necrotizing fasciitis, autoimmune bullous disease, or vascular insufficiency 1, 2

Diagnostic Approach

• The American Academy of Dermatology suggests considering infectious causes, such as necrotizing fasciitis, cellulitis with bullae formation, or secondary bacterial infection of traumatic blister, as the primary differential diagnosis for a non-healing single bulla 3, 2
• The British Journal of Dermatology recommends obtaining a Gram stain and culture of any fluid or exudate from the wound to identify causative organisms, which is essential before initiating antibiotics 3, 2
• Skin biopsy for histopathology and direct immunofluorescence is recommended if the presentation is atypical or autoimmune disease is suspected, to distinguish autoimmune bullous disease from infectious or traumatic causes 5, 2

Wound Care

• The British Journal of Dermatology suggests gently cleansing the ruptured bulla with antimicrobial solution, leaving any remaining blister roof in place as a biological dressing, and applying bland emollient to support barrier function and encourage re-epithelialization 1, 6, 2
• The British Journal of Dermatology recommends covering the wound with a non-adherent dressing if needed for protection or exudate absorption, and changing dressings using aseptic technique, particularly if erosions are extensive 1, 2

Infection Management

• The Infectious Diseases Society of America recommends semi-synthetic penicillin, first-generation cephalosporin, or clindamycin for mild infection without systemic symptoms, and empiric broad-spectrum coverage for suspected necrotizing infection with bullae 3, 2

Autoimmune Disease Management

• The American Academy of Dermatology suggests high-potency topical corticosteroid for localized autoimmune bullous disease, and oral prednisone with taper over at least 4 weeks once controlled for more extensive or progressive disease 5, 2

Monitoring and Follow-Up

• The British Journal of Dermatology recommends documenting daily the number, size, and location of blisters on a chart to track progression or improvement, and reevaluating within 24-48 hours if managed as outpatient to ensure appropriate response 1, 6, 7